Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > $7.03 SP after FDA announcement

<< Previous

Bullboard Posts

Next >>

Comment by Arrakis37on Aug 05, 2021 3:42pm

34 Views

Post# 33658446

RE:RE:RE:$7.03 SP after FDA announcement

Hello ? An answer could be appreciated

Arrakis37 wrote: No answer about that neither...

GunnerG wrote: Maybe the new ID can provide an explanation?

GunnerG wrote: and $2.93 close yesterday.

Provide the logic as to why the SP would drop 60% in 55 days StupsNewcamoTom